Exploring biology with small organic molecules

Nature

Volumn 432, Issue 7019, 2004, Pages 846-854

  Stockwell, Brent R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMICAL EQUIPMENT; MAPPING; PROTEINS;

BIOLOGICAL SYSTEMS; BIOLOGICAL-ACTIVITY SPACE; ORGANIC MOLECULES;

MOLECULES;

ORGANIC COMPOUND; PROTEIN DERIVATIVE;

BIOLOGY;

BINDING AFFINITY; CORRELATION ANALYSIS; DROSOPHILA MELANOGASTER; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; MATHEMATICAL COMPUTING; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; REACTION ANALYSIS; REPORTER GENE; REVIEW; SACCHAROMYCES CEREVISIAE; TECHNIQUE; TRANSCRIPTION INITIATION;

ANIMALS; BIOLOGY; CHEMISTRY, ORGANIC; DRUG EVALUATION, PRECLINICAL; PHENOTYPE; PROTEIN BINDING; SUBSTRATE SPECIFICITY;

ARACHNIDA; DROSOPHILA MELANOGASTER; HEXAPODA; MELANOGASTER; SACCHAROMYCES CEREVISIAE;

EID: 11144298973     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03196     Document Type: Review

References (75)

1. Brenner, S. The genetics of Caenorhabditis elegans. Gentrics 77, 71-94 (1974).
2. Hartwell, L. H. Twenty-five years of cell cycle genetics. Genetics 4, 975-80 (1991).
3. Stockwell, B. R. Chemical genetics: ligand-based discovery of gene function. Nature Rev. Genet. 1, 116-25 (2000).
4. Stockwell, B. R. Frontiers in chemical genetics. Trends Biotechnol. 18, 449-455 (2000).
5. Stockwell, B. R. Chemical genetic screening approaches to neurobiology. Neuron 36, 559-562 (2002).
6. Schreiber, S. L. The small-molecule approach to biology: chemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology. Chem. Eng. News 81, 51-61 (2003).
7. Schreiber, S. L. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6, 1127-1152 (1998).
8. Kuruvilla, F. G., Shamji, A. F., Sternson, S. M., Hergenrother, P. J. & Schreiber, S. L. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 416, 653-657 (2002).
9. Hannon, G. J. RNA interference. Nature 418, 244-251 (2002).
10. Moore, P. & Clayton, J. To affinity and beyond. Nature 426, 725-731 (2003).
11. Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964-1969 (2000).
12. Young, S. S. & Ge, N. Design of diversity and focused combinatorial libraries in drug discovery. Curr. Opin. Drug Discov. Dev. 7, 318-324 (2004).
13. Jimonet, P. & Jager, R. Strategies for designing GPCR-focused libraries and screening sets. Curr. Opin. Drug Discov. Dev. 7, 325-333 (2004).
14. Read, R. C. et al. Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries. J. Med. Chem. 47, 1641-1651 (2004).
15. Sodeoka, M. et al. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition. J. Med. Chem. 44, 3216-3222 (2001).
16. Stahura, F. L., Xue, L., Godden, J. W. & Bajorath, J. Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases. J. Mol. Graph Model 17, 1-9, 51-2 (1999).
17. Burke, M. D. & Schreiber, S. L. A planning strategy for diversity-oriented synthesis. Angew. Chem. Int. Edn Engl. 43, 46-58 (2004).
18. Spring, D. R. Diversity-oriented synthesis; a challenge for synthetic chemists. Org. Biomol. Chem. 1, 3867-3870 (2003).
19. Kubota, H., Lim, J., Depew, K. M. & Schreiber, S. L. Pathway development and pilot library realization in diversity-oriented synthesis: exploring Ferrier and Pauson-Khand reactions on a glycal template. Chem. Biol. 9, 265-276 (2002).
20. Couve-Bonnaire, S., Chou, D. T., Gan, Z. & Arya, P. A solid-phase, library synthesis of natural-product-like derivatives from an enantiomerically pure tetrahydroquinoline scaffold. J. Comb. Chem. 6, 73-77 (2004).
21. Arya, P., Wei, C. Q., Barnes, M. L. & Daroszewska, M. A solid phase library synthesis of hydroxyindoline-derived tricyclic derivatives by Mitsunobu approach. J. Comb. Chem. 6, 65-72 (2004).
22. Kauvar, L. M., Villar, H. O., Sportsman, J. R., Higgins, D. L. & Schmidt, D. E. J. Protein affinity map of chemical space. J. Chromatog. B 715, 93-102 (1998).
23. Greenbaum, D. C. et al. Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem. Biol. 9, 1085-1094 (2002).
24. Weinstein, J. N. et al. An information-intensive approach to the molecular pharmacology of cancer. Science 275, 343-349 (1997).
25. Lakey, J. H. & Raggett, E. M. Measuring protein-protein interactions. Curr. Opin. Struct. Biol. 8, 119-123 (1998).
26. Gray, N. S. et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281, 533-538 (1998).
27. Salemme, F. R. Chemical genomics as an emerging paradigm for postgenomic drug discovery. Pharmacogenomics 4, 257-267 (2003).
28. MacBeath, G., Koehler, A. N. & Schreiber, S. L. Printing small molecules as microarrays and detecting protein-ligand interactions en masse. J. Am. Chem. Soc. 121, 7967-7968 (1999).
29. Winssinger, N., Ficarro, S., Schultz, P. G. & Harris, J. L. Profiling protein function with small molecule microarrays. Proc. Natl Acad. Sci. USA 99, 11139-11144 (2002).
30. Falsey, J. R., Renil, M., Park, S., Li, S. & Lam, K. S. Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjug. Chem. 12, 346-353 (2001).
31. Vetter, D. Chemical microarrays, fragment diversity, label-free imaging by plasmon resonance - a chemical genomics approach. J. Cell Biochem. 39 (suppl.), 79-84 (2002).
32. Birkert, O., Tunnemann, R., Jung, G. & Gauglitz, G. Label-free parallel screening of combinatorial triazine libraries using reflectometric interference spectroscopy. Anal. Chem. 74, 834-840 (2002).
33. Birkert, O. & Gauglitz, G. Development of an assay for label-free high-throughput screening of thrombin inhibitors by use of reflectometric interference spectroscopy. Anal. Bioanal. Chem. 372, 141-147 (2002).
34. Jona, G. & Snyder, M. Recent developments in analytical and functional protein microarrays. Curr. Opin. Mol. Ther. 5, 271-277 (2003).
35. MacBeath, G. Protein microarrays and proteomics. Nature Genet. 32 (suppl.), 526-532 (2002).
36. Zhu, H. et al. Global analysis of protein activities using proteome chips. Science 293, 2101-2105 (2001).
37. Espejo, A., Cote, J., Bednarek, A., Richard, S. & Bedford, M. T. A protein-domain microarray identifies novel protein-protein interactions. Biochem. J. 367, 697-702 (2002).
38. Newman, J. R. & Keating, A. E. Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300, 2097-2101 (2003).
39. Ziauddin, J. & Sabatini, D. M. Microarrays of cells expressing defined cDNAs. Nature 411, 107-110 (2001).
40. Ramachandran, N. et al. Self-assembling protein microarrays. Science 305, 86-90 (2004).
41. Lefurgy, S. & Cornish, V. Finding Cinderella after the ball: a three-hybrid approach to drug target identification. Chem. Biol. 11, 151-153 (2004).
42. Liberles, S. D., Diver, S. T., Austin, D. J. & Schreiber, S. L. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc. Natl Acad. Sci. USA 94, 7825-7830 (1997).
43. Lunn, M. R. et al. Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem. Biol. 11, 1495-1503 (2004).
44. Dolma, S., Lessnick, S. L., Hahn, W. C. & Stockwell, B. R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285-296 (2003).
45. Wang, J. & Dreyfuss, G. A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN. J. Biol. Chem. 276, 9599-9605 (2001).
46. Aiken, C. T., Tobin, A. J. & Schweitzer, E. S. A cell-based screen for drugs to treat Huntington's disease. Neurobiol. Dis. 16, 546-555 (2004).
47. Stegmaier, K. et al. Gene expression-based high-throughput screening(GE-HTS) and application to leukaemia differentiation. Nature Genet. 36, 257-263 (2004).
48. Kapur, R. Fluorescence imaging and engineered biosensors: functional and activity-based sensing using high content screening. Ann. NY Acad. Sci. 961, 196-197 (2002).
49. Yarrow, J. C., Perlman, Z. E., Westwood, N. J. & Mitchison, T. J. A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC Biotechnol. 4, 21 (2004).
50. Kau, T. R. et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell 4, 463-476 (2003).
51. Root, D. E., Flaherty, S. P., Kelley, B. P. & Stockwell, B. R. Biological mechanism profiling using an annotated compound library. Chem. Biol. 10, 881-892 (2003).
52. Seidler, J., McGovern, S. L., Doman, T. N. & Shoichet, B. K. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46, 4477-4486 (2003).
53. Tuschl, T. Expanding small RNA interference. Nature Biotechnol. 20, 446-448 (2002).
54. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
55. Lassus, P., Rodriguez, J. & Lazebnik, Y. Confirming specificity of RNAi in mammalian cells. Sci. STKE 147, PL13 (2002).
56. Root, D. E., Kelley, B. P. & Stockwell, B. R. Global analysis of large-scale chemical and biological experiments. Curr. Opin. Drug Discov. Dev. 5, 355-360 (2002).
57. Burke, T. J., Loniello, K. R., Beebe, J. A. & Ervin, K. M. Development and application of fluorescence polarization assays in drug discovery. Comb. Chem. High Throughput Screen. 6, 183-194 (2003).
58. Timasheff, S. N., Andreu, J. M. & Na, G. C. Physical and spectroscopic methods for the evaluation of the interactions of antimitotic agents with tubulin. Pharmacol. Ther. 52, 191-210 (1991).
59. Bulseco, D. A. & Wolf, D. E. Fluorescence correlation spectroscopy: molecular complexing in solution and in living cells. Methods Cell Biol. 72, 465-498 (2003).
60. Misra, R. Modern drug development from traditional medicinal plants using radioligand receptor-binding assays. Med. Res. Rev. 18, 383-402 (1998).
61. Hicks, R. P. Recent advances in NMR: expanding its role in rational drug design. Curr. Med. Chem. 8, 627-650 (2001).
62. Siegel, M. M. Early discovery drug screening using mass spectrometry. Curr. Top. Med. Chem. 2, 13-33 (2002).
63. Homola, J. Present and future of surface plasmon resonance biosensors. Anal. Bioanal. Chem. 377, 528-539 (2003).
64. Jelesarov, I. & Bosshard, H. R. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J. Mol. Recogn. 12, 3-18 (1999).
65. Burke, M. D., Berger, E. M. & Schreiber, S. L. Generating diverse skeletons of small molecules combinatorially. Science 302, 613-618 (2003).
66. Oprea, T. I. & Matter, H. Integrating virtual screening in lead discovery. Curr. Opin. Chem. Biol. 8, 349-358 (2004).
67. Ewing, T. J., Makino, S., Skillman, A. G. & Kuntz, I. D. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des. 15, 411-428 (2001).
68. Osterberg, F., Morris, G. M., Sanner, M. F., Olson, A. J. & Goodsell, D. S. Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock Proteins 46, 34-40 (2002).
69. Kramer, B., Rarey, M. & Lengauer, T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 37, 228-241 (1999).
70. Halgren, T. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750-1759 (2004).
71. Vangrevelinghe, E. et al. Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. J. Med. Chem. 46, 2656-2662 (2003).
72. Peng, H. et al. Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg. Med. Chem. Lett. 13, 3693-3699 (2003).
73. Bajorath, J. Integration of virtual and high-throughput screening. Nature Rev. Drug Discov. 1, 882-894 (2002).
74. Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26 (2001).
75. Hann, M. M. & Oprea, T. I. Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol. 8, 255-263 (2004).